Twitter's money-grab move to charge for the verified user checkmark may have backfired. Eli Lilly is among those who have halted ad spending after fake blue-check accounts went viral. In the case of
the pharma giant, the fake account promised free insulin. "
By the time Twitter had removed the tweet, more than six hours later, the account had inspired other fake Eli Lilly
copycats
and been viewed millions of times," per the Washington Post. "By Friday morning, Eli Lilly executives had ordered a halt to all Twitter ad campaigns — a
potentially serious blow, given that the $330 billion company controls the kind of massive advertising budget that Musk says the company needs to avoid bankruptcy. They also paused their Twitter
publishing plan for all corporate accounts around the world."advertisement
advertisement
Read the whole story at Washington Post »
